Skip to main content
. 2011 Mar 14;121(4):1373–1385. doi: 10.1172/JCI42579

Figure 1. CD133 expression in primary and metastatic tumors in KrasLA1/+p53R172HΔG/+ mice and in syngeneic mice injected with 344SQ cells.

Figure 1

CD133 staining (green) in metastases to (A and B) heart, (C and D) diaphragm, (E and F) chest wall, and (G and H) liver and (I and J) a primary lung tumor from KrasLA1/+p53R172HΔG/+ mice, (K and L) in a primary subcutaneous tumor and (M and N) large and (O and P) small lung metastases from syngeneic mice injected with 344SQ cells, and in a primary subcutaneous tumor in mice injected with (Q and R) CD133hi and (S and T) CD133lo 344SQ tumor cells. Sections were costained with DAPI (blue). Under each CD133/DAPI-stained panel is a panel with hematoxylin and eosin staining of an adjacent tissue section. Original magnification, ×20 (AI and MT); ×4 (JL). Scale bars: 100 μm (AI, L, N, and PT); 200 μm (J and K); 50 μm (M and O).